Skip to main content
. 2021 Jan 21;29(5):1794–1807. doi: 10.1016/j.ymthe.2021.01.021

Figure 3.

Figure 3

The CD39+ HBVs-CAR-T cells exerted an enhanced effector function and a downregulation of inhibitory receptors

(A) Representative flow cytometry plots of CD107a and IFN-γ gated on CD39+/− HBVs-CAR-T cells after being co-cultured with autologous tumor organoids. GP120-CAR-T cells served as NC. (B and C) Relative quantification of IFN-γ and CD107a expression of CD39+/− CAR-T cells. Error bars represent SEMs of 3 biological replicates. (D) Flow cytometry analysis of inhibitory receptor expression of CD39+/− HBVs-CAR T cells.